COVID-19 vaccine: Assam hospital likely to be selected for Phase-II trials of Covaxin, says Himanta Biswa Sarma

By: |
August 14, 2020 7:51 PM

The Drugs Controller General of India granted permission to Bharat Biotech for Phase-I and II human clinical trials after it had submitted results generated from pre- clinical studies, demonstrating safety and immune response.

The Gauhati Medical College and Hospital (GMCH) is likely to be selected as one of the centres for Phase-II trial of ‘Covaxin’, the country’s first indigenous vaccine, Assam Health Minister Himanta Biswa Sarma said on Friday. Hyderabad-based Bharat Biotech has “successfully completed” Phase-I human clinical trials of the vaccine and
Phase-II will start soon, Sarma said at a plasma donation camp organised by the BJP here.

On June 29, Bharat Biotech had announced that it had successfully developed ‘Covaxin’ in collaboration with Indian
Council of Medical Research (ICMR) and National Institute of Virology (NIV). “They (Bharat Biotech) have started the process to have GMCH as one of the centres for Phase-II testing of the vaccine.

“It is almost 99 per cent sure that GMCH will participate (in Phase-II trials),” Sarma said. At present, paper work is going on between Bharat Biotech and Gauhati Medical College and Hospital (GMCH), he added.

The Drugs Controller General of India granted permission to Bharat Biotech for Phase-I and II human clinical trials after it had submitted results generated from pre- clinical studies, demonstrating safety and immune response.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1WHO, partners roll out faster Covid tests for poorer nations
2BJP leader Uma Bharti who tested Covid positive admitted to AIIMS
3Covid-19: Health ministry launches web portal for updates on vaccine development